Personalising Treatment of Soft Tissue Sarcomas and GIST

Speakers: Jean-Yves Blay, Angelo Paolo Dei Tos, and George Demetri

World experts discuss the impact of new classifications on the wealth of knowledge about sarcoma and GIST and question if it is still possible to treat them without molecular biology data. They also discuss key parameters influencing treatment decisions in localised and advanced disease. Finally they address the issue of heterogeneity and its impact on research.

Discussion Points

  • Can we treat sarcoma & GIST with no knowledge of molecular biology?
  • What are the key parameters which influence treatment decision making in sarcoma & GIST: at localised and in advanced phase?
  • How important would it be to address tumour heterogeneity: at local and in advanced phase?
  • How to address observance?